4.1K
Publications
196.3K
Citations
15.1K
Authors
3.2K
Institutions
HL-A27 Immunogenetic Linkage Era
1970 - 1976
The 1970–1976 period crystallized a genetic-immunogenetic paradigm in spondyloarthropathies, foregrounding Human Leukocyte Antigen 27 (HL-A27) as a shared susceptibility marker across ankylosing spondylitis, Reiter's syndrome, and related enthesopathies. Research emphasized enthesopathy and sacroiliac inflammatory lesions as core features, linking inflammatory bowel disease and other gastrointestinal manifestations within a unified disease spectrum and highlighting familial clustering as evidence of heritable risk. Population-level investigations began to use carrier status to refine prevalence estimates and risk stratification, laying groundwork for genetic screening approaches.
• Genetic and immunogenetic studies converge on HL-A27 as a pivotal marker linking ankylosing spondylitis and Reiter's syndrome, with multiple papers showing high W27 frequencies in affected individuals and familial patterns suggesting shared pathogenic pathways [1], [2], [17], [16], [W201? not present], [6].
• Enthesopathy and sacroiliac/inflammatory entheseal changes emerge as core pathology across spondyloarthritides, with pathology papers detailing enthesopathy and destructive vertebral lesions that frame AS and related conditions as unified diseases [3], [5], [18], [14].
• Gastrointestinal comorbidity appears linked with spondyloarthritides, with studies showing inflammatory bowel disease in AS and musculo-skeletal complications of Crohn’s disease, highlighting a systemic inflammatory spectrum [4], [10].
• Familial clustering and inheritance signals arise, including families with AS, Reiter's disease, and RA, and inheritance studies connecting HL-A27 status to disease occurrence, suggesting heritable risk factors [6], [17], [20].
• Epidemiologic implications of HL-A27 show how carrier status stratifies risk and guides population-level prevalence estimates, with healthy W27 individuals experiencing higher AS prevalence in some cohorts [13], [8], [7].
HLA-B27 Immunogenetics
1977 - 1983
HLA-B27 Immune Crosstalk
1984 - 1994
Genetics-Driven Standardization in Spondyloarthritis
1995 - 2001
TNF Blockade Paradigm
2002 - 2008
Spondyloarthritis Genetic-Immunologic Imaging Paradigm
2009 - 2015
Targeted Biologic Axial Spondyloarthritis
2016 - 2022